Active Ingredient History

NOW
  • Now
Taspoglutide is a former experimental drug, a glucagon-like peptide-1 agonist, that was under investigation for treatment of type 2 diabetes and being codeveloped by Ipsen and Roche.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
bim51077 | bim 51077 | bim-51077 | bim51079 | bim 51079 | bim-51079 | bim51182 | bim 51182 | bim-51182 | itm077 | itm 077 | itm-077 | r 1583 | r-1583 | r1583 cpd | ro-5073031 | taspoglutide

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue